RecruitingPhase 4ACTRN12612000211864

A comparison of propofol and dexmedetomidine for sedation during hip and knee arthoplasty.

A comparison of propofol and dexmedetomidine for sedation during hip and knee arthoplasty, in adults, assessing patient satisfaction and respiratory and cardiovascular stability.


Sponsor

Dr Mark Suss

Enrollment

40 participants

Start Date

Mar 11, 2012

Study Type

Interventional

Conditions

Summary

This trial will compare the sedative medicine propofol with the newer sedative dexmedetomidine. The comparison will take place in a group of patients having replacement of their hips or knees with mechanical joints. The study will look at patients undergoing this surgery under a spinal block, where the body is made numb from the waist downwards. Typically these patients have some sort of sedation to make them more comfortable and less aware of noise or movement in the operating theatre. The most commonly used infusion, propofol has some side effects including reduced breathing efforts, which sometimes requires the anaesthetist to intervene and support the airway or even convert the sedation to a full anaesthetic. A newer sedative medicine, dexmedetomidine appears to have fewer of these effects. It may be that it is a better option for this sort of sedation. Some mild side effects such as changes in pulse rate have been associated with dexmedetomidine but these do not appear to be severe enough to prevent its usefulness in this setting. Patients will be randomized to receive either propofol or dexmedetomidine. They will receive their normal regional (eg “spinal” ) anaesthetic. The researchers will be measuring: Patient satisfaction with the sedation experience (within one week of surgery); Need for airway support; and haemodynamic values intraoperatively.


Eligibility

Sex: Both males and femalesMin Age: 18 Yearss

Plain Language Summary

Simplified for easier understanding

This study is comparing two sedative medications — propofol (the most commonly used) and dexmedetomidine (a newer option) — in patients having hip or knee replacement surgery under spinal anaesthesia. During spinal anaesthesia, the body is numb from the waist down, and patients are often given a sedative to help them feel comfortable and relaxed. The study will look at patient satisfaction, breathing safety, and heart rate measurements. Participants will be randomly assigned to one of the two sedatives. You may be eligible if: - You are 18 years of age or older - You are having elective hip or knee replacement surgery - You are having the surgery under a spinal (neuraxial) block You may NOT be eligible if: - You have a medical reason that makes sedation unsafe or not recommended Talk to your doctor about whether this trial might be right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

The intervention will be usage of dexmedetomidine for sedation in assocation with neuraxial block for hip and knee arthroplasty. Dosage will be at the clinicians' discretion using standard dosages. Ho

The intervention will be usage of dexmedetomidine for sedation in assocation with neuraxial block for hip and knee arthroplasty. Dosage will be at the clinicians' discretion using standard dosages. However typical dosages are a loading dose of 0.5micrograms per kilogram (40micrograms for an 80kg patient) and 0.7 mcg/kg/hr, 56micrograms per kilogram per hour (56 micrograms an hour for an 80kg patient). Dosages are typically reduced for elderly patients. This would be given via intravenous infusion, commencing once the patient is positioned and it would not be combined with other sedative agents.


Locations(1)

Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12612000211864